A 69-year-old man presents with a high-risk transient ischaemic attack (unilateral weakness lasting 20 minutes). Imaging excludes haemorrhage and large vessel occlusion. He has no indication for anticoagulation. According to Canadian Stroke Best Practices, which antiplatelet strategy is recommended in the first 21 days after this event?